LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 2803 | 6849 | 0.4092 | 0.7873 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 2860 | 6849 | 0.4175 | 0.7918 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 3328 | 6849 | 0.4859 | 0.8263 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 3551 | 6849 | 0.5184 | 0.8413 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 1529 | 6849 | 0.2232 | 0.6561 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.08 | 27.76 | 4020 | 6849 | 0.5869 | 0.8703 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 2958 | 6893 | 0.4291 | 0.7983 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 2991 | 6893 | 0.4339 | 0.8008 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 3516 | 6893 | 0.5101 | 0.8377 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 3707 | 6893 | 0.5378 | 0.8500 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 883 | 6893 | 0.1281 | 0.5448 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 71.78 | 27.76 | 4171 | 6893 | 0.6051 | 0.8776 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 3081 | 6957 | 0.4428 | 0.8057 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 3117 | 6957 | 0.4480 | 0.8083 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 3673 | 6957 | 0.5279 | 0.8459 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 3816 | 6957 | 0.5485 | 0.8548 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 657 | 6957 | 0.0944 | 0.4874 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 73.48 | 27.76 | 4338 | 6957 | 0.6235 | 0.8849 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 3146 | 7015 | 0.4485 | 0.8088 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 3189 | 7015 | 0.4546 | 0.8119 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 3782 | 7015 | 0.5391 | 0.8510 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 3962 | 7015 | 0.5648 | 0.8618 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 372 | 7015 | 0.0530 | 0.3843 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.19 | 27.76 | 4438 | 7015 | 0.6326 | 0.8885 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.89 | 27.76 | 3264 | 7025 | 0.4646 | 0.8169 | MN20160318_Q01 | G09 |